ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1,4,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2,1,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
3,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
4,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
4,4,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
5,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
6,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
7,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
8,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
8,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
9,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
10,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
12,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
13,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,1,Animal bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
15,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
15,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
16,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
17,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
17,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
17,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
17,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,7,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
19,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
20,2,Headache,Headaches NEC,Headaches,Nerv,N
21,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
22,1,Hypercalciuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
23,1,Hypercalciuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
24,1,Urine calcium/creatinine ratio increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
25,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
25,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
26,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
26,2,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
27,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
28,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
29,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
29,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
30,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
30,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
30,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
30,4,Hypercalciuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
31,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
32,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
32,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
33,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
33,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
34,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
35,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
36,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
36,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
36,4,Hypercalciuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
36,5,Hyperparathyroidism primary,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
36,6,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
37,1,Finger deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
38,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
39,1,Exostosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
39,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
41,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
42,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
42,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
42,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
42,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
42,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
43,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
43,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
43,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
44,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
44,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
45,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
46,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
47,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
47,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
47,4,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
47,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
47,6,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
47,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
48,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,2,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
49,1,Migraine,Migraine headaches,Headaches,Nerv,N
49,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
50,1,Injection site plaque,Injection site reactions,Administration site reactions,Genrl,N
51,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
51,2,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
52,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,2,Headache,Headaches NEC,Headaches,Nerv,N
52,3,Product container seal issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
